Battery Recycling: Blood Lead at 48 µg/dL
A battery-recycling plant employs 24 production workers. Personal air monitoring during a 10-hour shift shows lead concentrations of 38–52 µg/m³; two samples exceed the 50 µg/m³ permissible exposure limit. Blood lead levels drawn last week show one worker at 48 µg/dL, three at 32–39, eight at 21–29, and the rest below 20. The worker with 48 µg/dL is asymptomatic and asks to keep working overtime because his family relies on the pay. The plant physician advises that no symptoms means no removal is needed. The company has supplied respirators, but fit-testing records are incomplete and two workers wear them intermittently. The state OSHA consultation service is scheduled to visit in three weeks. Management wants to delay changes until after the visit. No worker has been trained on lead’s reproductive risks.
1. Interpret the air and blood lead data together. What does the pattern suggest about exposure control, and what immediate action is warranted for the worker with 48 µg/dL?
Read the worked answer
The air data show that at least two personal samples exceed the 50 µg/m³ permissible exposure limit, and the range of 38–52 µg/m³ indicates that exposure is widespread rather than isolated to one task. The blood lead distribution reinforces this: one worker at 48 µg/dL, three at 32–39, and eight at 21–29 means that a substantial fraction of the 24-person workforce is absorbing lead above background. This is not a single-worker hygiene problem; it points to inadequately controlled inhalation and possibly ingestion from contaminated surfaces, clothing, or food areas.
For the worker at 48 µg/dL, symptoms are the wrong trigger. Lead toxicity is often silent, and neurological or renal effects can occur without acute symptoms. The worker is close to the medical-removal threshold of 50 µg/dL and should not simply continue overtime. Immediate actions are: notify the worker of the result in private; arrange a medical evaluation with a clinician familiar with occupational lead; remove or sharply reduce exposure pending evaluation; repeat the blood lead level to confirm; review the worker’s respirator use and hygiene facilities; and document the decision. The plant physician’s “no symptoms, no removal” advice is not adequate risk management.
2. Management proposes waiting three weeks for the consultation visit. Give a reasoned response, including one regulation-based and one risk-communication argument.
Read the worked answer
Waiting three weeks is not defensible. Regulation-based argument: personal air samples already exceed the permissible exposure limit, and the employer has a duty to implement engineering and work-practice controls, provide fit-tested respirators, and monitor blood lead levels according to the lead standard. A consultation visit is advisory, not a prerequisite for controlling a known overexposure. Delaying until after the visit leaves workers exposed at the same levels and may worsen the blood lead distribution.
Risk-communication argument: workers have already seen inconsistent respirator use and incomplete fit-testing. Telling them to wait because a state visit is coming signals that production matters more than their health. That erodes trust and makes future monitoring, removal, and training harder to implement. A better response is to tell workers what is known, what is being changed immediately, and when repeat testing will occur. Management can still use the consultation visit to review the plan, but the plan should be in place before the visit, not after it.
3. Design a 30-day monitoring and communication plan. Include at least one engineering control, one administrative control, and one worker-facing communication.
Read the worked answer
Engineering control: enclose or ventilate the battery-breaking and smelting areas, and add local exhaust ventilation at the points where dust is generated. Until installation is complete, restrict access and wet methods to suppress dust. Administrative control: rotate tasks to reduce individual exposure, ban eating and smoking in production areas, provide shower and change facilities, launder work clothing on site, and establish a written medical-removal policy with clear blood lead triggers. Fit-test all respirators and retrain workers on donning and doffing.
Monitoring: repeat personal air sampling within 7 days in the highest-exposure jobs; repeat blood lead levels for the worker at 48 µg/dL within 2 weeks and for all workers within 30 days; track results by job title rather than only by individual. Communication: hold a short all-hands meeting and give each worker a written result letter explaining what the number means, what the company is changing, and how to request a medical evaluation. Include reproductive health information in training, because lead affects both men and women. Report progress to workers at day 14 and day 30 so the plan is visible, not just promised.